Abstract: In various aspects and embodiments provided are compositions and methods for identifying patients in need of improving cognition and/or treating a neurodegenerative disease in a patient and treating such patient. More specifically, the disclosure in some embodiments includes administration of a ?-AR agonist and a peripherally acting ?-blocker (PABRA) to a patient in need thereof.
Abstract: In various aspects and embodiments provided are compositions and methods for a disease or disorder in a patient such as a disease or disorder that affects the brain in a patient and treating such patient.
Abstract: The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor.
Type:
Grant
Filed:
March 26, 2020
Date of Patent:
June 22, 2021
Assignee:
Curasen Therapeutics, Inc.
Inventors:
Anthony P. Ford, Wei Chen, David Scott Carter, Jiaxin Yu
Abstract: The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor.
Type:
Grant
Filed:
March 26, 2020
Date of Patent:
March 16, 2021
Assignee:
CuraSen Therapeutics, Inc.
Inventors:
Anthony P. Ford, Wei Chen, David Scott Carter, Jiaxin Yu
© 2024 Justia
